Connor, Clark & Lunn Investment Management (CC&L)’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Buy |
|
|||||
|
2025
Q1 | $4.42M | Sell |
|
|||||
|
2024
Q4 | $4.4M | Buy |
|
|||||
|
2024
Q3 | $4.57M | Sell |
|
|||||
|
2024
Q2 | $3.54M | Buy |
|
|||||
|
2024
Q1 | $3.23M | Buy |
|
|||||
|
2023
Q4 | $2.89M | Sell |
|
|||||
|
2023
Q3 | $2.08M | Buy |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $459K | Buy |
|
|||||
|
2022
Q4 | $466K | Buy |
|
|||||
|
2022
Q3 | $310K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $70K | Sell |
|
|||||
|
2020
Q2 | $1.42M | Buy |
|
|||||
|
2020
Q1 | $634K | Buy |
|